This study aimed at helping researchers understand how a medication called haloperidol can affect insulin action in the brain. Insulin is a hormone in the body that controls sugar levels in part by lowering the amount of glucose produced by the liver. After eating a meal, insulin levels go up in both the blood and the brain. Insulin in the brain has also been shown to affect the way the brain works and processes information (also known as "cognition"). Haloperidol, is an antipsychotic medication used to treat a variety of disorders such as schizophrenia spectrum disorders, bipolar disorder, and major depressive disorder, but long-term use can have metabolic side effects, like weight gain, type 2 diabetes, and cardiovascular disease. The purpose of this study is to investigate how antipsychotic medications, such as haloperidol, which carries the risk of metabolic changes, might interrupt the effect of insulin action in the brain. This will help researchers learn how to potentially reduce metabolic risk for people who take these kinds of medications in the future.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
RsFC between the anterior cingulate cortex of the salience network and the lateral parietal cortex of the DMN
Timeframe: From enrollment to the end of study will be up to 5 months
Metabolic Outcome: BMI
Timeframe: From enrollment to the end of study will be up to 5 months
Metabolic Outcome: Waist Circumference
Timeframe: From enrollment to the end of study will be up to 5 months
Metabolic Outcome: Glucose
Timeframe: From enrollment to the end of study will be up to 5 months
Metabolic Outcome: Insulin
Timeframe: From enrollment to the end of study will be up to 5 months
Metabolic Outcome: C-peptide
Timeframe: From enrollment to the end of study will be up to 5 months
Metabolic Outcome: HbA1c
Timeframe: From enrollment to the end of study will be up to 5 months
Metabolic Outcome: HOMA-IR (Homeostatic Model Assessment for Insulin Resistance)
Timeframe: From enrollment to the end of study will be up to 5 months